CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

By Luo Guopei   Xiao Zhiwen   Long Jiang   Liu Zuqiang   Liu Liang   Liu Chen   Xu Jin   Ni Quanxing   Yu Xianjun  

Journal of Gastrointestinal Surgery, Vol. 17, Iss. 12, 2013-12 ,pp. : 2092-2098

Springer Publishing Company

Access to resources Recommend Favorite

Preoperative Diagnosis of Lymph Node Metastasis in Biliary and Pancreatic Carcinomas: Evaluation of the Combination of Multi-detector CT and Serum CA19-9 Level

By Nanashima Atsushi   Sakamoto Ichiro   Hayashi Tomayoshi   Tobinaga Syuuichi   Araki Masato   Kunizaki Masaki   Nonaka Takashi   Takeshita Hiroaki   Hidaka Shigekazu   Sawai Terumitsu   Yasutake Toru   Nagayasu Takeshi  

Digestive Diseases and Sciences, Vol. 55, Iss. 12, 2010-12 ,pp. : 3617-3626

Springer Publishing Company

Access to resources Recommend Favorite

The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

By Singh Sundeep  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2491-2496

Springer Publishing Company

Access to resources Recommend Favorite

Echocardiographic Screening for Pulmonary Hypertension in Stable COPD Out-Patients and NT-proBNP as a Rule-Out Test

By Andersen Charlotte U.   Mellemkjær Søren   Nielsen-Kudsk Jens E.   Sønderskov Lene D.   Laursen Britt E.   Simonsen Ulf   Hilberg Ole  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 5, 2012-09 ,pp. : 505-512

Informa Healthcare

Access to resources Recommend Favorite

A prediction rule for estimating pancreatic cancer risk in chronic pancreatitis patients with focal pancreatic mass lesions with prior negative EUS-FNA cytology

By Cai Quan-Cai   Chen Yan   Xiao Yi   Zhu Wei   Xu Qin-Feng   Zhong Liang   Chen Shi-Yao   Zhang Min-Min   Wang Luo-Wei   Li Zhao-Shen  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 4, 2011-04 ,pp. : 464-470

Informa Healthcare

Access to resources Recommend Favorite